本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ATAI Life Sciences B.V.*

2.18
-0.0500-2.24%
盤後2.17-0.0100-0.46%19:35 EDT
成交量:123.96萬
成交額:272.15萬
市值:4.38億
市盈率:-2.34
高:2.25
開:2.22
低:2.16
收:2.23
資料載入中...
2021/06/08

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/04

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/27

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/24

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/24

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/11

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/20

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2020/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/31

非美公司披露報告

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/18

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/24

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/29

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/15

超過5%披露

General statement of acquisition of beneficial ownership
2019/08/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]